Skip to content
Screener

Sabra Healthcare SBRA Financing Cash Flow

Financing Cash Flow at other companies

VTR
VentasVTR
$89.96M+160%
Welltower logo
WelltowerWELL
-$199.54M-115%
Omega Healthcare Investors logo
Omega Healthcare InvestorsOHI
-$639.14M-209%
Strawberry Fields logo
Strawberry FieldsSTRW
-$17.34M-141%
CareTrust logo
CareTrustCTRE
$576.86M+59.4%
American Healthcare REIT logo
American Healthcare REITAHR
$89.46M+170%

Other financials

Income statement

See full
Revenue$221.8M+20.8%
Net income$40.9M+1.4%
EPS (diluted)$0.16-5.9%

Balance sheet

See full
Cash & equivalents$116.5M+414%
Total debt$7.3M-9.6%
Total equity$2.8B+3.1%
Total assets$5.6B+6.8%

Cash flow

See full
Operating cash flow$98.4M+22.5%

Valuation

See full
Market cap$5.34B+21.0%
Enterprise value$5.23B+20.9%
P/E34.2×+10.0×
P/S6.6×+0.5×

Profitability

See full
Net margin19.2%-0.3pp

Returns & leverage

See full
Return on equity5.7%+0.5pp
Debt / equity0.0×

Where this comes from

Reported directly by Sabra Healthcare in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The source filing: Sabra Healthcare’s 10-Q, filed April 29, 2026.

Filed
Apr 29, 2026, 4:06 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001492298-26-000012
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Payment of contingent consideration(1,178)
Issuance of common stock, net(8,247)(5,391)
Dividends paid on common stock(75,657)(71,373)
Net cash provided by (used in) financing activities52,099(101,242)
Net increase (decrease) in cash, cash equivalents and restricted cash45,371(37,423)
Effect of foreign currency translation on cash, cash equivalents and restricted cash(60)(19)
Cash, cash equivalents and restricted cash, beginning of period78,14066,339
Cash, cash equivalents and restricted cash, end of period$123,451$28,897

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Sabra Healthcare's financing cash flow?
Sabra Healthcare (SBRA) reported financing cash flow of $52.1M in Q1 2026.
How has Sabra Healthcare's financing cash flow changed year-over-year?
Sabra Healthcare's financing cash flow increased by 151.5% year-over-year, from -$101.24M to $52.1M.
What is the long-term trend for Sabra Healthcare's financing cash flow?
Over 2 years (2022 to 2024), Sabra Healthcare's financing cash flow has grown at a -16.1% compound annual growth rate (CAGR), from -$258.08M to -$181.56M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Ask your AI about Sabra Healthcare's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude